Fount Raises $12M for Personalized Performance Optimization

Fount Raises $12M for Personalized Performance Optimization Personalized protocols are replacing one-size-fits-all health recommendations. What’s happening: Fount, a high-performance health platform, raised $12M in a Series A round. The company plans to scale its 1:1 training platform while also launching new products for improved sleep and women’s health. What it is: Fount’s coaching platform focuses on structured self-experimentation to optimize health. Read More from the…

Odyssey Wellness Completes $6.3M Series A Private Equity Funding

Odyssey Wellness Completes $6.3M Series A Private Equity Funding FORT LAUDERDALE, Fla.–()–Odyssey Wellness (Odyssey), makers of Odyssey Elixir, the first sparkling energy drink infused with functional mushrooms, announced today that it has completed a $6.3M series A capital raise bringing the total funding since inception to $8.3M. The funding will enable the acceleration of Odyssey’s growth across all distribution channels. Read More from the Global Wellness…

Female-founded Wave Life Secures $6M Investment to Increase Mental Health Access for Gen Z

Female-founded Wave Life Secures $6M Investment to Increase Mental Health Access for Gen Z Wave Life, a mental health platform aimed at supporting Gen Z, has secured a $6M seed investment led by Santé Ventures, with participation from Hannah Grey, Joyance Capital, Gaingels, and Telocity Ventures. Read More from the Global Wellness News ™

Non-linear workdays

Non-linear workdays A new work day centered in mental wellness is showing promise for worker capacity and creative output. The pandemic forced companies and their employees to reformat where they could and should work each day. Now that flexible workplaces and hybrid office scheduling are more common, some companies are reconsidering when their employees might be most productive as well. Read More from the Global Wellness…

OpenAI’s 37-year-old CEO bet $180 million on a little-known biotech startup that’s trying to help people live 10 years longer

OpenAI’s 37-year-old CEO bet $180 million on a little-known biotech startup that’s trying to help people live 10 years longer From Jeff Bezos to Jack Dorsey, billionaires are using their wealth to fight aging. According to a report by MIT Technology Review, OpenAI CEO Sam Altman is among the group. Altman has quietly funded a longevity startup with $180 million, MIT Technology Review said. Anti-aging…

Save Your Cart
Share Your Cart